Imaging Biomarkers for TMS Treatment of Depression



Status:Completed
Conditions:Depression, Depression
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:22 - 65
Updated:5/12/2016
Start Date:September 2013
End Date:April 2016

Use our guide to learn which trials are right for you!

The purpose of this research is to learn more about how rTMS works to reduce the symptoms of
depression. This information can be used to improve the effectiveness of the treatment. The
study will use functional magnetic resonance imaging (fMRI) to examine changes in brain
function after treatment with rTMS. fMRI is a safe and painless technique that allows
investigators to observe the brain "at work." The investigators will use fMRI to see what
regions of the brain become active when you perform a concentration task and how that
activation is changed after rTMS.


Inclusion Criteria:

- Primary diagnosis of major depressive disorder

- Male and female subjects, ages 22-65

- Have failed at least 1 antidepressant medication at adequate dose and duration

- On stable antidepressant medication regimen for at least 4 weeks prior to TMS therapy

Exclusion Criteria:

- Diagnosed with a psychotic, bipolar, obsessive-compulsive or post-traumatic stress
disorder

- Active substance abuse, including alcohol

- Medical and/or neurological condition that could affect your brain function or risk
of seizure, including a stroke, epilepsy, or a closed head injury;

- No presence of an implanted device like a pacemaker/neurostimulator or metal in the
head or body;

- Pregnant or trying to get pregnant

- Failed to respond to an adequate course of electroconvulsive therapy (ECT)

- Previous treatment with TMS

- Current depressive episode longer than 5 years
We found this trial at
1
site
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials